The purpose of this study is to assess treatment patterns, physician reported clinical outcomes and patient-reported health-related quality of life (HRQoL) among patients diagnosed with R/R-DLBCL not receiving autologous stem cell transplant (ASCT) and initiating second- or third-line therapy. In addition, the aim of the Real-MIND study is to enroll patients belonging to racial and ethnic minorities with a good gender, age and socio-economic status balance in order to gain the best representation of the US population.~This non-interventional study will collect real-world data on treatments and clinical outcomes as per usual care. This protocol does not recommend the use of any specific treatments or assessments.
REAL-MIND: Prospective multicenter observational study of patients with relapsed or refractory diffuse large B-cell lymphoma starting second- or third-line therapy and not receiving autologous stem cell transplant